AstraZeneca: meeting with an FDA advisory committee
On Friday, AstraZeneca reported on yesterday's meeting with an FDA advisory committee concerning its application to market its Imfinzi immunotherapy for the treatment of operable non-small cell lung cancer. According to AstraZeneca, the FDA's …